tradingkey.logo
tradingkey.logo
検索

Tempus AI Inc

TEM
ウォッチリストに追加
43.870USD
-0.420-0.95%
終値 07-31 16:00ET15分遅れの株価
7.92B時価総額
損失額直近12ヶ月PER

詳細情報 Tempus AI Inc 企業名

Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.

Tempus AI Incの企業情報

企業コードTEM
会社名Tempus AI Inc
上場日May 30, 2025
最高経営責任者「CEO」Lefkofsky (Eric P)
従業員数2400
証券種類Ordinary Share
決算期末May 30
本社所在地600 West Chicago Avenue
都市CHICAGO
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号60654
電話番号18335144187
ウェブサイトhttps://investors.tempus.com/
企業コードTEM
上場日May 30, 2025
最高経営責任者「CEO」Lefkofsky (Eric P)

Tempus AI Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Ryan Fukushima
Mr. Ryan Fukushima
Chief Operating Officer
Chief Operating Officer
693.91K
-23.89%
Mr. Peter J. Barris
Mr. Peter J. Barris
Independent Director
Independent Director
112.64K
+5.25%
Mr. Andrew (Andy) Polovin
Mr. Andrew (Andy) Polovin
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
30.28K
+4.28%
Mr. Eric D. Belcher
Mr. Eric D. Belcher
Independent Director
Independent Director
26.67K
+22.17%
Mr. David R. Epstein
Mr. David R. Epstein
Independent Director
Independent Director
16.68K
-1.50%
Dr. Scott Gottlieb, M.D.
Dr. Scott Gottlieb, M.D.
Independent Director
Independent Director
14.80K
+91.55%
Mr. James (Jim) Rogers
Mr. James (Jim) Rogers
Chief Financial Officer
Chief Financial Officer
14.52K
-79.38%
Mr. Eric P. Lefkofsky, J.D.
Mr. Eric P. Lefkofsky, J.D.
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Erik J. Phelps, J.D.
Mr. Erik J. Phelps, J.D.
Executive Vice President, Chief Administrative and Legal Officer, Assistant Secretary
Executive Vice President, Chief Administrative and Legal Officer, Assistant Secretary
--
--
Dr. Jennifer A. Doudna, Ph.D.
Dr. Jennifer A. Doudna, Ph.D.
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Ryan Fukushima
Mr. Ryan Fukushima
Chief Operating Officer
Chief Operating Officer
693.91K
-23.89%
Mr. Peter J. Barris
Mr. Peter J. Barris
Independent Director
Independent Director
112.64K
+5.25%
Mr. Andrew (Andy) Polovin
Mr. Andrew (Andy) Polovin
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
30.28K
+4.28%
Mr. Eric D. Belcher
Mr. Eric D. Belcher
Independent Director
Independent Director
26.67K
+22.17%
Mr. David R. Epstein
Mr. David R. Epstein
Independent Director
Independent Director
16.68K
-1.50%
Dr. Scott Gottlieb, M.D.
Dr. Scott Gottlieb, M.D.
Independent Director
Independent Director
14.80K
+91.55%

よくある質問

Tempus AI Incの上位5名の株主は誰ですか?

Tempus AI Incの上位5名の株主は以下のとおりです。Mr. Ryan Fukushima

Tempus AI Inc(TEM)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Tempus AI Incの株式を保有している機関は847社あり、保有株式の総市場価値は約109.28Mで、全体の62.62%を占めています。2025Q4と比較して、機関の持ち株は6294807.00増加しています。
tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。